Why Teva Pharmaceutical Stock Is Sinking Today
Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m. ET. The leg down comes as the S&P 500 ( ^GSPC -0.86%) and Nasdaq Composite ( ^IXIC -1.18%) lost 0.5% and 0.9%, respectively.
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report)’s share price was down 4.6% on Thursday after UBS Group lowered their price target on the stock from $30.00 to $27.00. UBS Group ...
Teva Pharmaceutical (TEVA) stock falls as the generic drugmaker with its Q4 2024 results set its 2025 earnings outlook below ...
Argus Research analyst Jasper Hellweg maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) yesterday. The company’s shares ...
Despite finishing strong across both its innovative and generic businesses in 2024, Teva’s cautious approach to the new year ...
We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...
Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback